LOCKHART STEPHEN 4
4 · Emergent BioSolutions Inc. · Filed May 11, 2010
Insider Transaction Report
Form 4
LOCKHART STEPHEN
SVP, Product Development
Transactions
- Exercise/Conversion
Common Stock
2010-05-10$7.00/sh+10,800$75,600→ 17,780 total - Sale
Common Stock
2010-05-10$15.56/sh−10,800$168,048→ 6,980 total - Exercise/Conversion
Employee Stock Option (right to buy)
2010-05-10−10,800→ 5,400 totalExercise: $7.00Exp: 2015-03-10→ Common Stock (10,800 underlying)
Footnotes (1)
- [F1]The option will vest with respect to the remaining 5,400 shares on March 11, 2011.